Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers from Technical ...

(NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...

Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...

AnaptysBio (ANAB) stock climbs as its antibody therapy rosnilimab meets key goals in mid-stage rheumatoid arthritis trial, ...

Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Researchers at the (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites.

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...